Skip to main content
. 2019 Aug 29;8:F1000 Faculty Rev-1530. [Version 1] doi: 10.12688/f1000research.17174.1

Table 1. Indications for pulmonary valve replacement in current guidelines.

European Society of Cardiology
(2010) 77
American College of Cardiology/American Heart
Association (2008) 75
Canadian Cardiovascular
Society (2009) 76
Class I Symptomatic patients with severe PR
and/or
PS (RV systolic pressure >60 mm Hg,
TR velocity >3.5 m/s)
Severe PR
and
Symptoms or decreased exercise tolerance
Class IIa Severe PR or PS (or both)
and either:
Severe PR
and either:
Free PR
and either:
RV size Moderate to severe RV enlargement EDVi 170 mL/m 2
Progression of
RV size
Progressive RV dilation Progressive RV dilation
RV function Progressive RV dysfunction Moderate to severe RV
dysfunction
Moderate to severe RV
dysfunction
TR Progressive TR, at least moderate Moderate to severe TR Important TR
PS PS RV systolic pressure greater than
80 mm Hg, TR velocity 4.3 m/s
Peak instantaneous echocardiography gradient
greater than 50 mm Hg
or
RV/LV pressure ratio greater than 0.7
or
Residual RVOT obstruction (valvular or subvalvular)
with progressive and/or severe dilatation of the RV
with dysfunction
RV pressure at least 2/3
systemic pressure
Exercise
capacity
Decrease in objective exercise
capacity
Symptoms such as
deteriorating exercise
performance
Arrhythmia Sustained atrial or ventricular
arrhythmia
Symptomatic or sustained atrial and/or ventricular
arrhythmias
Atrial or ventricular
arrhythmia

EDVi, end-diastolic volume index; LV, left ventricle; PR, pulmonary regurgitation; PS, pulmonary stenosis; RV, right ventricle; RVOT, right ventricle outflow tract; TR, tricuspid regurgitation.